logo

For the Inventor, By the Inventor

Sollentuna, Sweden

Linda Fryklund

This inventor holds 6 USPTO granted patents. Top assignees: Kabivitrum Ab, Chiron Corporation, Kabi Pharmacia Ab. Active years: 1990-2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Linda Fryklund. Retrieved from https://idiyas.com/inventor/linda-fryklund

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6

% Patents Active = 100.0

Average Co-Inventor Count = 4.3

ph-index = 5

Forward Citations = 205(Granted Patents)


Location History:

  • Sollentune, SE (1996)
  • Sollentuna, SE (1990 - 2000)

Company Filing History:

goldMedal2 out of 29 
 
Kabivitrum Ab
 patents
silverMedal1 out of 672 
 
Chiron Corporation
 patents
bronzeMedal1 out of 27 
 
Kabi Pharmacia Ab
 patents
4. 1 out of 47 
 
Pharmacia & Upjohn Aktiebolag
 patents
5. 1 out of 184 
 
Pharmacia Ab
 patents

Years Active: 1990-2000

Loading Chart...
6 patents (USPTO):Explore Patents
1. 6034059 - Treatment of catabolic states using authentic IGF-1 and hypocaloric (2000-03-07),
2. 5872097 - Oligopeptides with affinity to opioid receptors (1999-02-16),
3. 5545144 - Method and device for dosing a liquid preparation (1996-08-13),
4. 5273966 - O-glycosylated IGF-1 (1993-12-28),
5. 5068224 - Method of improving regeneration of transfected peripheral nerves using (1991-11-26),
6. 4968299 - Method and device for injection (1990-11-06),

Title: Linda Fryklund: Innovator in Biopharmaceuticals

Introduction

Linda Fryklund is a prominent inventor based in Sollentuna, Sweden. She has made significant contributions to the field of biopharmaceuticals, holding a total of six patents. Her work focuses on innovative treatments that address various medical conditions.

Latest Patents

Among her latest patents are groundbreaking inventions such as the treatment of catabolic states using authentic IGF-1 and hypocaloric oligopeptides with affinity to opioid receptors. These patents reflect her commitment to advancing medical science and improving patient outcomes.

Career Highlights

Throughout her career, Linda has worked with notable companies, including Kabivitrum AB and Kabi Pharmacia AB. Her experience in these organizations has allowed her to develop and refine her innovative ideas, contributing to the advancement of biopharmaceutical research.

Collaborations

Linda has collaborated with esteemed colleagues, including Birger Hjertman and Anders Strom. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise.

Conclusion

Linda Fryklund's contributions to the field of biopharmaceuticals through her patents and collaborations highlight her role as a leading innovator. Her work continues to inspire advancements in medical treatments and research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…